Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Daprodustat in Chronic Kidney Disease (CKD) Anemia for Understanding Real-World Evidence (REDCURE)

NCT07346547 is registered in ClinicalTrials.gov with Nabiqasim Industries (Pvt) Ltd as lead sponsor.

NCT NCT07346547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Daprodustat in Chronic Kidney Disease (CKD) Anemia for Understanding Real-World Evidence (REDCURE)
Lead sponsor
Nabiqasim Industries (Pvt) Ltd
Phase
Observational
Overall status
Not yet recruiting
Start date
January 30, 2026
Completion date
May 31, 2027
Enrollment
384 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ckd anemia